Stock Research for AEMD

AEMD
Current Price

$1.4800


Latest Update: 2018-02-20 16:00:00

High
$ 1.4800
Low
$ 1.4800
Close
$ 1.4800
Volume
300
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

AEMD Stock Chart & Research Data

The AEMD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AEMD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AEMD Due diligence Resources & Stock Charts

The AEMD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AEMD Detailed Price Forecast - CNN Money CNN View AEMD Detailed Summary - Google Finance
Yahoo View AEMD Detailed Summary - Yahoo! Finance Zacks View AEMD Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View AEMD Trends & Analysis - Trade-Ideas Barrons View AEMD Major Holders - Barrons
NASDAQ View AEMD Call Transcripts - NASDAQ Seeking View AEMD Breaking News & Analysis - Seeking Alpha
Spotlight View AEMD Annual Report - CompanySpotlight.com OTC Report View AEMD OTC Short Report - OTCShortReport.com
TradeKing View AEMD Fundamentals - TradeKing Charts View AEMD SEC Filings - Bar Chart
WSJ View Historical Prices for AEMD - The WSJ Morningstar View Performance/Total Return for AEMD - Morningstar
MarketWatch View the Analyst Estimates for AEMD - MarketWatch CNBC View the Earnings History for AEMD - CNBC
StockMarketWatch View the AEMD Earnings - StockMarketWatch MacroAxis View AEMD Buy or Sell Recommendations - MacroAxis
Bullish View the AEMD Bullish Patterns - American Bulls Short Pains View AEMD Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View AEMD Stock Mentions - StockTwits PennyStocks View AEMD Stock Mentions - PennyStockTweets
Twitter View AEMD Stock Mentions - Twitter Invest Hub View AEMD Investment Forum News - Investor Hub
Yahoo View AEMD Stock Mentions - Yahoo! Message Board Seeking Alpha View AEMD Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for AEMD - SECform4.com Insider Cow View Insider Transactions for AEMD - Insider Cow
CNBC View AEMD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AEMD - OTC Markets
Yahoo View Insider Transactions for AEMD - Yahoo! Finance NASDAQ View Institutional Holdings for AEMD - NASDAQ


Stock Charts

FinViz View AEMD Stock Insight & Charts - FinViz.com StockCharts View AEMD Investment Charts - StockCharts.com
BarChart View AEMD Stock Overview & Charts - BarChart Trading View View AEMD User Generated Charts - Trading View


Latest Financial News for AEMD

Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting
Posted on Monday February 12, 2018

SAN DIEGO, Feb. 12, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that its CEO, Jim Joyce will give a presentation at the 2018 American Society for Microbiology (ASM) Biothreats Meeting.  The presentation entitled: "A Broad-Spectrum Platform to Address Life-Threating Viral Infections," is scheduled to begin at 8:30am eastern on February 14th.  The presentation slide-deck will be made available on the Aethlon Medical website at https://www.aethlonmedical.com/news-media/presentations. The American Society for Microbiology Biothreats Meeting is being held today, February 12th through the 14th at the Hilton, Baltimore Md.  The event includes tracks on high consequence pathogen research, biological threat reduction, product development, and policy.


AEMD: Q3 Results. Hemopurifier Pathway Could Benefit From New FDA Mindset
Posted on Tuesday February 06, 2018

By Brian Marckx, CFA NASDAQ:AEMD Fiscal Q3 2018 Financials, Operational Update Aethlon Medical (NASDAQ:AEMD) reported financial results for their fiscal third quarter 2018 ending December 31st and provided ...


Aethlon Medical Announces Fiscal 2018 Third Quarter Results
Posted on Thursday February 01, 2018

SAN DIEGO , Feb. 1, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal ...


Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018
Posted on Monday January 29, 2018

SAN DIEGO , Jan. 29, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue third ...


Aethlon Medical Announces Fiscal 2018 Third Quarter Results
PR Newswire (press release) - Feb 1, 2018
Aethlon is also investigating the potential therapeutic use of the Hemopurifier® to reduce the presence of tumor-derived exosomes, which contribute to immune-suppression and the spread of metastasis in cancer patients.
Aethlon Medical's (AEMD) CEO Jim Joyce on Q3 2018 Results - Earnings Call ... - Seeking Alpha

Aethlon Medical breaks out, shares up 38%
Seeking Alpha - Dec 13, 2017
Nano cap Aethlon Medical (AEMD +37.5%) breaks out of a two-month base on more than a 6x surge in volume. No particular news accounts for the action.

Aethlon Medical Announces Allowance of US Patent that Broadens Protection for ...
PR Newswire (press release) - Jan 18, 2018
SAN DIEGO, Jan. 18, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced that the United States Patent and Trademark Office has allowed U.S ...
Aethlon Medical (AEMD) Receives Patent that Broadens Protection for ... - StreetInsider.com
Analyst Stock Recommendations For GEE Group, Inc. (JOB), Aethlon Medical, Inc ... - Analyst Journal

Aethlon Medical Announces Large-Scale Production Collaboration
PR Newswire (press release) - Oct 16, 2017
SAN DIEGO, Oct. 16, 2017 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that it has established a collaboration with iBio, Inc. (NYSE ...
Aethlon Medical, Inc. (NASDAQ:AEMD) Partners with iBio Inc. - Stock News Union (blog)

Enter a stock symbol to view the stock details.